MedPath

A randomised controlled two part study to evaluate the effectiveness of different education methods to achieve serum phosphate levels set by the Renal Association for haemodialysis patients.

Completed
Conditions
rological and Genital Diseases: Haemodialysis
Urological and Genital Diseases
Haemodialysis
Registration Number
ISRCTN38137821
Lead Sponsor
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
68
Inclusion Criteria

Patients will be recruited from Barts and The London NHS Trust haemodialysis population. This includes hospital and satellite units.
1. Serum phosphate: >1.7 mmol/l
2. Serum calcium: 2.2 - 2.6 mmol/l
3. Serum parathyroid hormone (PTH): 10-50 pmol.

Exclusion Criteria

Not provided at time of registration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Group 1 (both interventions): results for phosphate knowledge and serum phosphate control should be the best out of all the groups<br>Groups 2 + 3 (each had one intervention only, group teaching session and intensive clinic respectively): results for phosphate knowledge and serum phosphate control should improve versus baseline<br>Group 4 (control): results for phosphate knowledge and serum phosphate control should be similar to baseline
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath